Elanco Animal Health Incorporated (ELAN)
Market Cap | 6.64B |
Revenue (ttm) | 4.42B |
Net Income (ttm) | -1.23B |
Shares Out | 492.97M |
EPS (ttm) | -2.50 |
PE Ratio | n/a |
Forward PE | 14.51 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 4,785,031 |
Open | 13.00 |
Previous Close | 12.93 |
Day's Range | 12.98 - 13.73 |
52-Week Range | 7.88 - 16.88 |
Beta | 1.30 |
Analysts | Hold |
Price Target | 16.29 (+21.03%) |
Earnings Date | May 8, 2024 |
About ELAN
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticid... [Read more]
Full Company ProfileFinancial Performance
In 2023, ELAN's revenue was $4.42 billion, an increase of 0.14% compared to the previous year's $4.41 billion. Losses were -$1.23 billion, 1478.2% more than in 2022.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for ELAN stock is "Hold." The 12-month stock price forecast is $16.29, which is an increase of 21.03% from the latest price.
News
Elanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement
GREENFIELD, Ind. , April 17, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2024 financial results on Wednesday, May 8, 2024.
Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors
New Directors Join the Board's Renamed Finance, Strategy and Oversight Committee Reaches Cooperation Agreement with Ancora GREENFIELD, Ind. , April 1, 2024 /PRNewswire/ -- Elanco Animal Health Incorpo...
Activist investor Ancora secures two Elanco board seats, Bloomberg News reports
Investment firm Ancora Holdings has reached an agreement with Elanco Animal Health to add two of its director candidates to the company's board, Bloomberg News reported late on Sunday, citing people w...
Elanco Animal Health (ELAN) CEO on Pet Disease Prevention & Health Products
Elanco Animal Health (ELAN) offers pet disease prevention and nutritional health products. CEO Jeffrey Simmons joins Oliver Renick to give an overview of the company.
Elanco Appoints Shiv O'Neill as General Counsel and Corporate Secretary
GREENFIELD, Ind. , March 4, 2024 /PRNewswire/ -- Elanco Animal Health (NYSE: ELAN) announced today the appointment of Shiv O'Neill as the company's Executive Vice President, General Counsel and Corpor...
Elanco Animal Health is Executing on Plan to Deliver for Shareholders
Ancora Nominates Director Candidates Despite Elanco's Meaningful Operational Progress and Good Faith Engagement with the Investor GREENFIELD, Ind. , Feb. 29, 2024 /PRNewswire/ -- Elanco Animal Health ...
Ancora Nominates Four Highly Qualified, Independent Director Candidates and Urges Orderly CEO Succession at Elanco Animal Health
CLEVELAND--(BUSINESS WIRE)--Ancora Holdings Group, LLC (together with its affiliates, “Ancora” or “we”), which owns approximately 3% of the outstanding common stock of Elanco Animal Health Incorporate...
Elanco Animal Health Reports Fourth Quarter and Full Year 2023 Results
Fourth Quarter 2023 Financial Results: Revenue of $1,035 million Reported Net Loss of $141 million, Adjusted Net Income of $39 million Adjusted EBITDA of $165 million or 15.9% of Revenue Reported EPS ...
Elanco to Participate in Upcoming Investor Conferences
GREENFIELD, Ind. , Feb. 22, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced that the Company will participate in the following investor conferences.
Beef 'agtech' company Cattler launches interface with Elanco for its Benchmark program
SARATOGA, Calif. , Feb. 8, 2024 /PRNewswire/ -- Cattler ( www.cattler.farm) announces the launch of its interface with Elanco Animal Health Incorporated (NYSE: ELAN), as part of the agreement reached...
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2023 Financial Results Announcement
GREENFIELD, Ind. , Feb. 8, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its fourth quarter and full year 2023 financial results on Monday, February 26, 2024.
Merck to Buy Elanco's Aqua Business for $1.3 Billion
Merck struck a deal to buy Elanco Animal Health's aqua business in a deal that expands the drugmaker's animal-health business.
Merck to buy Elanco Animal Health's aqua business for $1.3 bln
Merck said on Monday it had agreed to buy Elanco Animal Health's aqua business for $1.3 billion in cash, to strengthen its portfolio of aquatic healthcare products.
Elanco Animal Health agrees to sell aqua business to Merck for $1.3 billion in cash
Elanco Animal Health Inc. ELAN, -0.41% said Monday it has agreed to sell its aqua business to Merck Animal Health MRK, +0.02% for $1.3 billion in cash. Greenfield, Ind.
Merck Animal Health to Acquire Elanco's Aqua Business
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced t...
Elanco Announces Sale of Aqua Business for $1.3 Billion
Transaction reinforces Elanco's commitment to most significant value creation opportunities in pet health and livestock sustainability Enables company to accelerate debt paydown by $1.05B to $1.1B GRE...
Tonisity and Elanco Announce Receipt of Permission from the Japanese Government for Tonisity Px Import and Sales
Tonisity and Elanco to Expand Partnership into the Japanese Swine Market Greenfield, Indiana, Fort Collins, Colorado, Basel, Switzerland and Dublin, Ireland--(Newsfile Corp. - January 31, 2024) - Elan...
Elanco Animal Health CEO Jeff Simmons goes one-on-one with Jim Cramer
Elanco Animal Health President and CEO Jeff Simmons joins 'Mad Money' host Jim Cramer to talk its targeted treatment for parvovirus, the pet medicine market, working with Bayer and more.
Elanco Launches Multi-Year Mission to Save 1 Million Puppies from Canine Parvovirus
Calling all Veterinarians and Pet Lovers - Take the "Defend Puppies. Defeat Parvo.
Stifel: ‘party is just getting started' in this stock up 80%
Elanco Animal Health Inc (NYSE: ELAN) has already gained a whopping 80% over the past two months but a Stifel analyst is convinced that the “party is just getting started”.
Elanco Animal Health Announces Planned Board Leadership Changes and Corporate Governance Actions
Lawrence Kurzius to become next Chairman of the Board GREENFIELD, Ind. , Jan. 2, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) announced today that the Board of Directors has nam...
Ancora picks up a stake in Elanco. How the investor may push to help improve margins
A refreshment of the board may be on the horizon at the animal health company.
Elanco to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on January 8-10, 2024. Jeff Simmons, president a...
Elanco to Participate in Evercore ISI 6th Annual HealthCONx Conference
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Evercore ISI 6th Annual HealthCONx Conference, November 28-29, 2023. Todd Young, Executive Vice Presid...
Elanco Animal Health Reports Third Quarter 2023 Results
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today reported financial results for the third quarter of 2023, provided guidance for the fourth quarter of 2023, and ...